STOCK TITAN

Shuttle Pharma: UDC gained control on September 9

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) said it expects to file its Form 10-Q for the quarter ended September 30, 2026, no later than the fifth calendar day following the prescribed filing date. It could not timely compile all required information, primarily because of its change-in-control analysis.

Management determined control changed on September 9, 2026, in connection with the conversion of certain Series B-1 Preferred Stock into common stock. As of September 14, former United Dogecoin Inc. stockholders beneficially owned approximately 2,554,982 shares, or approximately 53.6% of SHPH’s outstanding common stock, after giving effect to the stated 4.99% beneficial ownership limitations and certain pre-funded warrants. SHPH will account for the conversion as a reverse asset acquisition, with UDC as accounting acquirer; the quarterly report’s historical financial information will be UDC’s, and results are expected to differ significantly from the prior-year period. Co-CEO Chris Cooper signed the notification.

Common shares beneficially owned Approximately 2,554,982 shares Aggregate beneficial ownership of former UDC stockholders as of September 14, 2026, after giving effect to the stated limitations and certain pre-funded warrants.
Share of outstanding common stock Approximately 53.6% Former UDC stockholders’ aggregate beneficial ownership as of September 14, 2026.
Beneficial ownership limitation 4.99% Limitation in the terms of the Series B-1 Preferred Stock and certain pre-funded warrants held by former UDC stockholders.
reverse asset acquisition technical
"account for the issuance of the UDC Conversion Shares as a reverse asset acquisition"
accounting acquirer technical
"with UDC as the accounting acquirer"
The accounting acquirer is the party identified under accounting rules as having obtained control in a business combination; it is the entity that prepares the combined financial statements and records the purchase accounting entries. It matters to investors because that designation determines how the deal’s assets, liabilities, fair-value adjustments and goodwill are measured and reported, which affects reported earnings, balance sheet strength and comparability — like deciding which company’s books become the baseline after a merger.
beneficial ownership limitations financial
"4.99% beneficial ownership limitations set forth in the terms"
Beneficial ownership limitations are rules or contractual caps that restrict how much of a company’s stock an individual or entity can be treated as owning or controlling for legal, regulatory or corporate-governance purposes. They matter to investors because such limits affect voting power, reporting obligations, takeover risk and the ability to increase a stake — like an elevator weight limit or a lane divider that prevents any one car from taking over the whole road.
pre-funded warrants financial
"certain pre-funded warrants also held by the Former UDC Stockholders"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why is SHPH’s Form 10-Q late?

Shuttle said it could not timely compile all information required for its Form 10-Q for the quarter ended September 30, 2026, primarily because of its change-in-control analysis. It expects to file no later than the fifth calendar day following the prescribed filing date.

How many SHPH shares did former UDC stockholders beneficially own?

As of September 14, 2026, former United Dogecoin Inc. stockholders beneficially owned approximately 2,554,982 shares of SHPH common stock, representing approximately 53.6% of outstanding common stock after giving effect to the stated beneficial ownership limitations and certain pre-funded warrants.

When did UDC obtain control of SHPH?

Management determined that control passed on September 9, 2026, in connection with issuance of the UDC Conversion Shares, not when the previously disclosed merger with UDC closed.

Who will be the accounting acquirer in SHPH’s quarterly report?

UDC will be the accounting acquirer under the reverse asset acquisition treatment SHPH determined to apply to the issuance of the UDC Conversion Shares. The report’s historical financial information, including results of operations and financial statements, will be UDC’s.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

 

(Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

 

  For Period Ended: September 30, 2026
     
  ☐ Transition Report on Form 10-K
   
  ☐ Transition Report on Form 20-F
   
  ☐ Transition Report on Form 11-K
   
  ☐ Transition Report on Form 10-Q
   
  ☐ Transition Report on Form N-SAR
   
  For the Transition Period Ended:  

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Full Name of Registrant
 
 
Former Name if Applicable
 
401 PROFESSIONAL DRIVE SUITE 260
Address of Principal Executive Office (Street and Number)
 
GAITHERSBURG, MD 20879
City, State and Zip Code

 

 

 

 
 

 

PART II — RULES 12b-25 (b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

  (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
     
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

 

The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the disclosures required to be included in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026 (the “Quarterly Report”), primarily as a result of the change in control analysis described further below in Part IV(3). The Registrant expects to file the Quarterly Report no later than the fifth calendar day following the prescribed filing date.

 

SEC 1344 (04-09)   Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

(Attach extra Sheets if Needed)

 

PART IV — OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

   
 

Chris Cooper

 

(240)

 

403-4212

  (Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
      Yes ☒ No ☐
 

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
      Yes ☒ No ☐
   
  If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
   
 

As part of the Registrant’s review and preparation of its quarterly financial statements for the period ended September 30, 2026, management of the Registrant, in consultation with the Registrant’s advisors, determined that a change in control of the Registrant occurred on September 9, 2026 in connection with the conversion of certain of its issued and outstanding shares of Series B-1 Preferred Stock (the “B-1 Preferred Stock”) into shares (the “UDC Conversion Shares”) of the Registrant’s common stock, par value $0.00001 per share (“Common Stock”). As of September 14, 2026, the former stockholders (the “Former UDC Stockholders”) of United Dogecoin Inc., a Delaware corporation (“UDC”), beneficially owned an aggregate of approximately 2,554,982 shares of Common Stock, representing approximately 53.6% of the Registrant’s outstanding Common Stock, after giving effect to the 4.99% beneficial ownership limitations set forth in the terms of the B-1 Preferred Stock and certain pre-funded warrants also held by the Former UDC Stockholders.

 

As a result of the change in control described above, the Registrant has determined to account for the issuance of the UDC Conversion Shares as a reverse asset acquisition, with UDC as the accounting acquirer. This determination is consistent with the Registrant’s prior conclusion that UDC did not obtain control of the Registrant upon the closing of the Registrant’s previously disclosed merger with UDC, because control passed only upon the issuance of the UDC Conversion Shares. Accordingly, the historical financial information, including the results of operations and financial statements, to be included in the Quarterly Report will be that of UDC, rather than that of the Registrant prior to the issuance of the UDC Conversion Shares. The Registrant therefore anticipates that its results of operations reflected in the Quarterly Report will differ significantly from the results previously reported by the Registrant for the corresponding period of the prior fiscal year.

 

 
 

 

SHUTTLE PHARMACEUTICALS HOLDINGS, INC.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 17, 2026 By: /s/ Chris Cooper
      Chris Cooper
      Co-CEO

 

 

 

Keep reading